OECD Report: Tackling Harmful Alcohol Use
New OECD Report a reminder that new Government must tackle alcohol crisis with urgency – BSG
BSG alcohol health experts have responded to today's OECD Report by calling on the new Government to introduce a range of measures to address alcohol-related problems, which cost the Government £21bn every year.
The report, Tackling Harmful Alcohol Use: Economics and Public Health Policy, shows that whilst average alcohol consumption is apparently falling in some European countries:
- Levels of alcohol consumption in the UK are above the OECD average and have increased during the last 30 years
- The proportion of 15 year olds who have experienced alcohol increased from 71% in 2002 to 75% in 2010
- In England, the heaviest-drinking 20% of the population drink almost 63% of all alcohol
The BSG has repeated calls for a range of measures to be introduced to address the current crisis, including the introduction of an Alcohol Care Team in every hospital in the country, the introduction of a 50p minimum unit price for alcohol and restrictions of the advertising of alcohol, particularly towards children.
Commenting, British Society of Gastroenterology Alcohol Services Lead, Dr Kieran Moriarty CBE, said:
"This Europe-wide report comes at a critical moment for Britain, and we hope it will act as an urgent reminder to the incoming Government of the need to introduce a range of evidence-based policies to address the crisis we face.
"We have made considerable progress in recent years by increasing the number of Alcohol Care Teams, but we need more service improvements and for the Government to introduce a whole range of measures to address the situation we face.
"Our A&Es and wards are under great pressure and it is no secret that alcohol misuse has a major part to play in this.
"There is not a family in Britain unaffected by alcohol misuse and taking action will save the NHS money and, more importantly, save lives."
New RCP Guidance on Commissioning in Secondary Care
Commissioning secondary care in England: what does it all mean?
In 2013, the NHS in England underwent significant changes that introduced a new set of structures for commissioning and providing healthcare. The system of planning, delivering and funding healthcare services can seem complex, and technical terms are often used to describe commissioning and related issues such as contracting.
This practical guide, published by the Royal College of Physicians, is designed to help make sense of commissioning, contracting and related issues including the NHS payment system. It aims to help physicians in England to influence the way that patient care is planned and provided in their local area and nationally.
Cancer Genetics in Clinical Practice
A Guide to Cancer Genetics in Clinical Practice
BSG member Sue Clark has recently published a new textbook 'A GUIDE TO CANCER GENETICS IN CLINICAL PRACTICE' which has a significant gastroenterology content.
This book covers the basic concepts of cancer genetics. The common inherited cancer syndromes are each dealt with in greater depth, with the current management outlined. It is aimed at all clinicians who may encounter these conditions in their practice. The book sets out to facilitate identification of high-risk individuals and families, to inform interaction with geneticists and other sub-specialists, to provide a basis for patient management and to stimulate interest in these fascinating conditions.
View Flyer / Purchasing Details [ 38 Kb ]
Publication date: June 2009
BSG Guidance on Coeliac Disease 2010
The Management of Adults with Coeliac Disease
There is clear evidence that coeliac disease is a common gastrointestinal disease affecting up to 1% of the adult population. Individuals may go undetected for many years. This is despite multiple presentations to both primary and secondary care. This may reflect that fact that affected individuals have subtle gastrointestinal symptoms or no gastrointestinal symptoms.
An active case finding strategy will increase the number of patients detected with coeliac disease. Testing for coeliac disease should incorporate an IgA level, Tissue Transglutaminase antibody and/or Endomysial antibody (depending on what is locally available). In patients with a positive antibody a duodenal biopsy should be undertaken to confirm the presence of villous atrophy. In patients who are antibody negative but the clinician is suspicious then a duodenal biopsy should still be undertaken having ensured that the patient is not on a self-imposed gluten-free diet (GFD).
The cornerstone of treatment is a GFD. Patients require regular dietetic support with the opportunity or access to a gastroenterologist should further problems arise. Follow-up may be in primary or secondary care as long as the support is adequate (as noted previously).
In patients with persisting symptoms they should be investigated carefully with particular reference to ensuring that refractory coeliac disease is excluded.
BSG Response to White Paper: 'Healthy Lives, Healthy People'
Responses to Public Health White Paper: 'Healthy Lives, Healthy People: Our Strategy for Public Health in England'
Submitted 31st March 2011
- BSG Response [ 270 kb ]
The organisations that contributed to the joint response are:
- The British Association for the Study of the Liver
- The British Society of Gastroenterology
- The British Liver Trust
- The Hepatitis C Trust
- Alcohol Concern
- Joint Response [ 528 kb ]
Page 4 of 15